Data / Drug companies / United Natural Foods, Inc. DBA Unfi
United Natural Foods, Inc. DBA Unfi: 216 products in the FDA NDC directory, labeler code 41163
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
United Natural Foods, Inc. DBA Unfi (labeler code 41163) lists 216 products in the FDA National Drug Code Directory, covering 104 finished drugs by generic name. By type: 216 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 2, 2025.
The request: Watch United Natural Foods, Inc. DBA Unfi (FDA labeler code 41163): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 41163
- Products in commercial distribution
- 216
- Packages
- 296
- Finished drugs by generic name
- 104
- Prescription products
- 0
- Over the counter products
- 216
- Flagged as original packager
- 206 of 206 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 9
- Earliest marketing start
- March 2, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 166 | 76.9% |
| Generic drugs (ANDA) | 45 | 20.8% |
| New drug applications (NDA) | 4 | 1.9% |
| Unapproved homeopathic products | 1 | 0.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 216 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 23 | 10.6% |
| Tablet | 23 | 10.6% |
| Liquid | 21 | 9.7% |
| Tablet, chewable | 18 | 8.3% |
| Solution | 17 | 7.9% |
| Tablet, coated | 15 | 6.9% |
| Capsule, liquid filled | 12 | 5.6% |
| Mouthwash | 8 | 3.7% |
| Cream | 7 | 3.2% |
| Suspension | 6 | 2.8% |
| Spray | 6 | 2.8% |
| Lotion | 5 | 2.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Equaline childrens cold and cough | 41163-260 | Solution | Over the counter monograph drugs | October 2, 2025 |
| Menstrual Relief | 41163-391 | Tablet, film coated | Over the counter monograph drugs | September 3, 2024 |
| Equaline Stomach Relief | 41163-535 | Liquid | Over the counter monograph drugs | May 13, 2024 |
| Equaline Ultra Strength Antacid Assorted Berry Ultra strength Assorted Fruit Antacid | 41163-184 | Tablet, chewable | Over the counter monograph drugs | May 12, 2024 |
| EQU Ultra Strength Antacid Assorted Fruit 171AF | 41163-171 | Tablet, chewable | Over the counter monograph drugs | May 12, 2024 |
| Equaline Stomach Relief | 41163-123 | Tablet | Over the counter monograph drugs | May 12, 2024 |
| Equqline Regular Strength Antacid | 41163-131 | Tablet, chewable | Over the counter monograph drugs | May 1, 2024 |
| Equaline Extra Strength Assorted Berry Antacid | 41163-129 | Tablet, chewable | Over the counter monograph drugs | May 1, 2024 |
| Equqline Extra Strength Antacid Assorted Fruit | 41163-125 | Tablet, chewable | Over the counter monograph drugs | May 1, 2024 |
| EQUALINE Regular Strength Antacid Peppermint | 41163-132 | Tablet, chewable | Over the counter monograph drugs | April 30, 2024 |
| Equaline dual action pain reliever | 41163-103 | Tablet, film coated | Generic drugs (ANDA) | March 21, 2024 |
| Gas Relief | 41163-773 | Capsule, liquid filled | Over the counter monograph drugs | November 30, 2023 |
| Equaline Effervescent Pain Reliever | 41163-741 | Tablet, effervescent | Over the counter monograph drugs | November 3, 2023 |
| Equaline Zinc Oxide Sunscreen Stick SPF 50 | 41163-969 | Stick | Over the counter monograph drugs | September 14, 2023 |
| Equaline Sport Continuous Sunscreen SPF 70 | 41163-968 | Spray | Over the counter monograph drugs | September 12, 2023 |
| Equaline Eye Drops A.C. | 41163-540 | Solution | Over the counter monograph drugs | March 22, 2023 |
| Equaline Advanced Relief Eye Drops | 41163-338 | Solution/ drops | Over the counter monograph drugs | March 19, 2023 |
| Alcohol | 41163-975 | Liquid | Over the counter monograph drugs | February 2, 2023 |
| Severe Cold | 41163-053 | Tablet, film coated | Over the counter monograph drugs | January 27, 2023 |
| Stool Softener Laxative | 41163-107 | Capsule, liquid filled | Over the counter monograph drugs | December 30, 2022 |
| Acetaminophen | 41163-592 | Tablet, coated | Over the counter monograph drugs | September 15, 2022 |
| Head Congestion plus Flu Severe | 41163-713 | Tablet, coated | Over the counter monograph drugs | August 19, 2022 |
| Head Congestion Plus Mucus PE | 41163-712 | Tablet, coated | Over the counter monograph drugs | August 19, 2022 |
| Maximum strength antacid cherry | 41163-065 | Liquid | Over the counter monograph drugs | June 10, 2022 |
| Equaline adult tussin | 41163-813 | Solution | Over the counter monograph drugs | June 8, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.